Aktas B (2023) Gut microbial alteration in MPTP Mouse Model of Parkinson Disease is Administration Regimen Dependent. Cell Mol Neurobiol 1–15. https://doi.org/10.1007/s10571-023-01319-7

Beilharz J, Kaakoush N, Maniam J, Morris M (2018) Cafeteria diet and probiotic therapy: cross talk among memory, neuroplasticity, serotonin receptors and gut microbiota in the rat. Mol Psychiatry 23(2):351–361. https://doi.org/10.1038/mp.2017.38

Article  PubMed  CAS  Google Scholar 

Bové J, Perier C (2012) Neurotoxin-based models of Parkinson’s disease. Neuroscience 211:51–76. https://doi.org/10.1016/j.neuroscience.2011.10.057

Article  PubMed  CAS  Google Scholar 

Brigas HC, Ribeiro M, Coelho JE, Gomes R, Gomez-Murcia V, Carvalho K et al (2021) IL-17 triggers the onset of cognitive and synaptic deficits in early stages of Alzheimer’s disease. Cell Rep 36(9):109574. https://doi.org/10.1016/j.celrep.2021.109574

Article  PubMed  CAS  Google Scholar 

Camacho-Soto A, Gross A, Nielsen SS, Dey N, Racette BA (2018) Inflammatory bowel disease and risk of Parkinson’s disease in Medicare beneficiaries. Parkinsonism Relat Disord 50:23–28. https://doi.org/10.1016/j.parkreldis.2018.02.008

Article  PubMed  PubMed Central  Google Scholar 

Caruso R, Lo BC, Núñez G (2020) Host–microbiota interactions in inflammatory bowel disease. Nat Rev Immunol 20(7):411–426. https://doi.org/10.1038/s41577-019-0268-7

Article  PubMed  CAS  Google Scholar 

Chapman TM, Plosker GL, Figgitt DP (2006) VSL# 3 probiotic mixture: a review of its use in chronic inflammatory bowel diseases. Drugs 66:1371–1387. https://doi.org/10.2165/00003495-200666100-00006

Article  PubMed  CAS  Google Scholar 

Chen Q, Haikal C, Li W, Li J-Y (2019a) Gut inflammation in association with pathogenesis of Parkinson’s disease. Front Mol Neurosci 218. https://doi.org/10.3389/fnmol.2019.00218

Chen X, Fu Y, Wang L, Qian W, Zheng F, Hou X (2019b) Bifidobacterium longum and VSL# 3® amelioration of TNBS-induced colitis associated with reduced HMGB1 and epithelial barrier impairment. Dev Comp Immunol 92:77–86. https://doi.org/10.1016/j.dci.2018.09.006

Article  PubMed  CAS  Google Scholar 

Dias AM, Douhard R, Hermetet F, Regimbeau M, Lopez TE, Gonzalez D et al (2021) Lactobacillus stress protein GroEL prevents colonic inflammation. J Gastroenterol 56:442–455. https://doi.org/10.1007/s00535-021-01774-3

Article  PubMed  CAS  Google Scholar 

Ding J-H, Jin Z, Yang X-X, Lou J, Shan W-X, Hu Y-X et al (2020) Role of gut microbiota via the gut-liver-brain axis in digestive diseases. World J Gastroenterol 26(40):6141. https://doi.org/10.3748/wjg.v26.i40.6141

Article  PubMed  PubMed Central  CAS  Google Scholar 

Distrutti E, O’Reilly J-A, McDonald C, Cipriani S, Renga B, Lynch MA et al (2014) Modulation of intestinal microbiota by the probiotic VSL# 3 resets brain gene expression and ameliorates the age-related deficit in LTP. PLoS ONE 9(9):e106503. https://doi.org/10.1371/journal.pone.0106503

Article  PubMed  PubMed Central  CAS  Google Scholar 

Ford AC, Achkar J-P, Khan KJ, Kane SV, Talley NJ, Marshall JK et al (2011) Efficacy of 5-aminosalicylates in ulcerative colitis: systematic review and meta-analysis. Official J Am Coll Gastroenterology| ACG 106(4):601–616. https://doi.org/10.1038/ajg.2011.67

Article  CAS  Google Scholar 

García-Domínguez I, Veselá K, García-Revilla J, Carrillo-Jiménez A, Roca-Ceballos MA, Santiago M et al (2018) Peripheral inflammation enhances microglia response and nigral dopaminergic cell death in an in vivo MPTP model of Parkinson’s disease. Front Cell Neurosci 398. https://doi.org/10.3389/fncel.2018.00398

Gil-Cardoso K, Ginés I, Pinent M, Ardévol A, Blay M, Terra X (2016) Effects of flavonoids on intestinal inflammation, barrier integrity and changes in gut microbiota during diet-induced obesity. Nutr Res Rev 29(2):234–248. https://doi.org/10.1017/S0954422416000159

Article  PubMed  CAS  Google Scholar 

Heng Y, Li Y-Y, Wen L, Yan J-Q, Chen N-H, Yuan Y-H (2022) Gastric enteric glial cells: a New Contributor to the synucleinopathies in the MPTP-Induced parkinsonism mouse. Molecules 27(21):7414. https://doi.org/10.3390/molecules27217414

Article  PubMed  PubMed Central  CAS  Google Scholar 

Heo JY, Nam M-H, Yoon HH, Kim J, Hwang YJ, Won W et al (2020) Aberrant tonic inhibition of dopaminergic neuronal activity causes motor symptoms in animal models of Parkinson’s disease. Curr Biol 30(2):276–291. https://doi.org/10.1016/j.cub.2019.11.079

Article  PubMed  CAS  Google Scholar 

Herrera J, Espinosa-Oliva AM, Oliva-Martin AJ, Carrillo-Jimenez M, Venero AL, J and, de Pablos M, R (2015) Collateral damage: contribution of peripheral inflammation to neurodegenerative diseases. Curr Top Med Chem 15(21):2193–2210. https://doi.org/10.2174/1568026615666150610142027

Article  PubMed  CAS  Google Scholar 

Jeon M-T, Kim K-S, Kim ES, Lee S, Kim J, Hoe H-S et al (2021) Emerging pathogenic role of peripheral blood factors following BBB disruption in neurodegenerative disease. Ageing Res Rev 68:101333. https://doi.org/10.1016/j.arr.2021.101333

Article  PubMed  CAS  Google Scholar 

Kam T-I, Hinkle JT, Dawson TM, Dawson VL (2020) Microglia and astrocyte dysfunction in parkinson’s disease. Neurobiol Dis 144:105028. https://doi.org/10.1016/j.nbd.2020.105028

Article  PubMed  PubMed Central  CAS  Google Scholar 

Kim W, Im MJ, Park CH, Lee CJ, Choi S, Yoon B-J (2013) Remodeling of the dendritic structure of the striatal medium spiny neurons accompanies behavioral recovery in a mouse model of Parkinson’s disease. Neurosci Lett 557:95–100. https://doi.org/10.1016/j.neulet.2013.10.049

Article  PubMed  CAS  Google Scholar 

Kumar M, Kissoon-Singh V, Coria AL, Moreau F, Chadee K (2017) Probiotic mixture VSL# 3 reduces colonic inflammation and improves intestinal barrier function in Muc2 mucin-deficient mice. Am J Physiology-Gastrointestinal Liver Physiol 312(1):G34–G45. https://doi.org/10.1152/ajpgi.00298.2016

Article  Google Scholar 

Lai F, Jiang R, Xie W, Liu X, Tang Y, Xiao H et al (2018) Intestinal pathology and gut microbiota alterations in a methyl-4-phenyl-1, 2, 3, 6-tetrahydropyridine (MPTP) mouse model of Parkinson’s disease. Neurochem Res 43:1986–1999. https://doi.org/10.1007/s11064-018-2620-x

Article  PubMed  CAS  Google Scholar 

Lee Y, Lee S, Chang S-C, Lee J (2019) Significant roles of neuroinflammation in Parkinson’s disease: therapeutic targets for PD prevention. Arch Pharm Res 42:416–425. https://doi.org/10.1007/s12272-019-01133-0

Article  PubMed  CAS  Google Scholar 

Li W, Wu X, Hu X, Wang T, Liang S, Duan Y et al (2017) Structural changes of gut microbiota in Parkinson’s disease and its correlation with clinical features. Sci China Life Sci 60:1223–1233. https://doi.org/10.1007/s11427-016-9001-4

Article  PubMed  Google Scholar 

Lin J-C, Lin C-S, Hsu C-W, Lin C-L, Kao C-H (2016) Association between Parkinson’s disease and inflammatory bowel disease: a nationwide Taiwanese retrospective cohort study. Inflamm Bowel Dis 22(5):1049–1055. https://doi.org/10.1097/MIB.0000000000000735

Article  PubMed  Google Scholar 

Mayer EA, Nance K, Chen S (2022) The gut–brain axis. Annu Rev Med 73:439–453. https://doi.org/10.1146/annurev-med-042320-014032

Article  PubMed  CAS  Google Scholar 

Meng C, Feng S, Hao Z, Dong C, Liu H (2022) Changes in gut microbiota composition with age and correlations with gut inflammation in rats. PLoS ONE 17(3):e0265430. https://doi.org/10.1371/journal.pone.0265430

Article  PubMed  PubMed Central  CAS  Google Scholar 

Menozzi E, Macnaughtan J, Schapira AH (2021) The gut-brain axis and Parkinson disease: clinical and pathogenetic relevance. Ann Med 53(1):611–625. https://doi.org/10.1080/07853890.2021.1890330

Article  PubMed  PubMed Central  CAS  Google Scholar 

Meredith GE, Rademacher DJ (2011) MPTP mouse models of Parkinson’s disease: an update. J Parkinson’s Disease 1(1):19–33. https://doi.org/10.3233/JPD-2011-11023